Liquidia Corp LQDA

NAS: LQDA | ISIN: US53635D2027 30/04/2025

13,97 USD (+3,40%)

(+3,40%) 30/04/2025

Grafiek Liquidia Corp

Grafiek Liquidia Corp

1 dag1d 3,40%
1 week1w -0,43%
1 maand1m -3,72%
3 maanden3m -2,51%
6 maanden6m 27,23%
1 jaar1j 6,07%
5 jaar5j 310,88%

Liquidia Corp in het nieuws

Toon enkel gratis nieuws

5 september 2024 · Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Against Liquidia Technologies, Inc. (LQDA) and Encourages Shareholders to Seek Compensation for Alleged Wrongdoings · Persbericht

28 augustus 2024 · Bronstein, Gewirtz and Grossman, LLC Announces an Investigation Against Liquidia Technologies, Inc. (LQDA) and Encourages Shareholders to Seek Compensation for Alleged Wrongdoings · Persbericht

2 november 2022 · Anavasi Diagnostics Announces Newly Elected Outside Board Of Directors · Persbericht

1 maart 2022 · Pathalys Pharma, Inc. Launches with Mission to Address High Priority Needs in Chronic Kidney Disease · Persbericht

7 juni 2021 · United Therapeutics Pursues New Claims For Trade Secret Misappropriation Against Liquidia · Persbericht

9 maart 2021 · Liquidia Corporation to Host 2020 Financial Results Conference Call on March 23, 2021 · Persbericht

2 maart 2021 · Liquidia Corporation Secures $20.5 Million Debt Facility with Silicon Valley Bank · Persbericht

Profiel Liquidia Corp

Gezondheidstechnologie

Medicinale en botanische productie

Website: liquidia.com

Hoofdzetel: Durham, North Carolina Verenigde Staten

CEO: Neal Fowler

Werknemers: 78

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe